Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine
/in HIV/AIDS, International PublicationsCognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
/in Breast Cancer, Dendritic Cells, International PublicationsEffective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
/in Breast Cancer, International PublicationsInfluence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer
/in Breast Cancer, International PublicationsCancer immunotherapy: stress proteins and hyperthermia
/in Dendritic Cells, Hyperthermia, International PublicationsCalcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid CancerReduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12
/in Chronic Virus Hepatitis, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer